This study will examine the safety of tivanisiran sodium eye drops versus vehicle when dosed once daily for 1 year in subjects with signs and symptoms of dry eye disease (DED).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
301
1 drop in the affected eye(s) once daily
1 drop in the affected eye(s) once daily
Sylentis Investigative Site
Chandler, Arizona, United States
Number and Percentage of Subjects With Ocular and Non-ocular Treatment Emergent Adverse Events (TEAEs) for 1 Year
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Sylentis Investigative Site
Phoenix, Arizona, United States
FYDES Investigative Site
Glendale, California, United States
Sylentis Investigative Site
Hemet, California, United States
Sylentis Investigative Site
Los Angeles, California, United States
Sylentis Investigative Site
Murrieta, California, United States
Sylentis Investigative Site
Newport Beach, California, United States
FYDES Investigative Site
Delray Beach, Florida, United States
FYDES Investigative Site
Jacksonville, Florida, United States
Sylentis Investigative Site
Largo, Florida, United States
...and 15 more locations